Sodium-Glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome With Diabetes Mellitus-Reference-Cited by-同舟云学术

Sodium-Glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome With Diabetes Mellitus

Published:2024-03 Issue: Volume:214 Page:47-54
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kurozumi Atsumasa^ORCID,Shishido Koki,Yamashita Takayoshi,Sato Daisuke,Uchida Syuhei,Koyama Eiji,Tamaki Yusuke,Hayashi Takahiro,Miyashita Hirokazu,Yokoyama Hiroaki,Ochiai Tomoki,Yamaguchi Masashi,Moriyama Noriaki,Tobita Kazuki,Matsumoto Takashi,Mizuno Shingo,Yamanaka Futoshi,Tanaka Yutaka,Murakami Masato,Takahashi Saeko,Saito Shigeru

Publisher

Elsevier BV

Reference38 articles.

1. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD;Cosentino;Eur Heart J,2020

2. Diabetes and restenosis;Wilson;Cardiovasc Diabetol,2022

3. Coronary revascularization of patients with diabetes mellitus in the setting of acute coronary syndromes;Godoy;Circulation,2019

4. Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: a retrospective observational study;Zhang;Medicine,2022

5. SGLT2 Inhibitor: not a traditional diuretic for heart failure;Verma;Cell Metab,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography;Cardiovascular Diabetology;2024-07-22

2. Breaking new ground in lipid management: Insights from the 2024 American College of Cardiology Scientific Sessions;Pharmacological Research;2024-07

3. Are Sodium-Glucose Cotransporter-2 Inhibitors Fantastic for Coronary Plaque Stabilization?;The American Journal of Cardiology;2024-07

4. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?;Current Hypertension Reports;2024-06-24

5. The Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis;Cureus;2024-04-11